Soligenix, Inc. (SNGX) – Management Comments
-
Soligenix, Inc. (SNGX) Issues Corporate Update on NDA Plans for HyBryte
-
Soligenix, Inc. (SNGX) to Advance Synthetic Hypericin Development in Psoriasis
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SNGX Stock Lookup